DOI QR코드

DOI QR Code

Improving the quality of the esophagogastroduodenoscopy in Helicobacter pylori-negative gastric cancer

  • Jae Myung Park (Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2023.04.29
  • Accepted : 2023.06.12
  • Published : 2023.07.30

Abstract

Keywords

References

  1. Kim SY, Park JM. Quality indicators in esophagogastroduodenoscopy. Clin Endosc 2022;55:319-331. https://doi.org/10.5946/ce.2022.094
  2. Mi EZ, Mi EZ, di Pietro M, et al. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Gastrointest Endosc 2018;87:408-418. https://doi.org/10.1016/j.gie.2017.06.028
  3. Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 2010;34:609-619. https://doi.org/10.1097/PAS.0b013e3181d94d53
  4. Ishibashi F, Hirasawa T, Ueyama H, Minato Y, Suzuki S. Exploring quality indicators for the detection of Helicobacter pylori-naive gastric cancer: a cross-sectional nationwide survey. Clin Endosc 2023;56:460-469.
  5. Park JM, Huo SM, Lee HH, Lee BI, Song HJ, Choi MG. Longer observation time increases proportion of neoplasms detected by esophagogastroduodenoscopy. Gastroenterology 2017;153:460-469. https://doi.org/10.1053/j.gastro.2017.05.009